SNC
MDCO

Stifel Nicolaus & Co’s Medicines Co MDCO Stock Holding History

Stifel Nicolaus & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$505K Buy
15,080
+1,980
+15% +$63.1K 0.01% 893
2013
Q2 		$403K Buy
+13,100
New +$438K 0.01% 943

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Nicolaus & Co's MDCO Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Medicines Co (MDCO) stake by 15% in Q3 2013, buying an estimated $63.1K and bringing the position to 15,080 shares worth $505K. The position accounts for 0.01% of the portfolio, ranked #893.

Stifel Nicolaus & Co first reported a position in MDCO in Q2 2013 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

  • Stifel Nicolaus & Co held 15,080 shares of Medicines Co worth $505K as of Q3 2013.
  • Stifel Nicolaus & Co bought 1,980 Medicines Co shares in Q3 2013, an estimated $63.1K.
  • Medicines Co made up 0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #893 holding.
  • Stifel Nicolaus & Co first reported a position in Medicines Co in Q2 2013 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.